Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
DarioHealth ( (DRIO) ) has provided an announcement.
On January 29, 2026, stockholders of DarioHealth Corp. approved an Amended and Restated Certificate of Incorporation, and the company filed the Amended Charter with the Delaware Secretary of State on February 2, 2026. The amendment expressly authorizes the board of directors to alter and repeal the company’s bylaws, while preserving stockholders’ power to alter or repeal them as well, effectively clarifying and potentially streamlining the company’s corporate governance framework.
The most recent analyst rating on (DRIO) stock is a Hold with a $11.00 price target. To see the full list of analyst forecasts on DarioHealth stock, see the DRIO Stock Forecast page.
Spark’s Take on DRIO Stock
According to Spark, TipRanks’ AI Analyst, DRIO is a Neutral.
The score is held down primarily by weak financial performance (large losses and continued cash burn) and bearish technical trend signals. These are partially offset by constructive earnings-call guidance focused on margin strength, client retention, cost reductions, and a path toward breakeven, while valuation is difficult to anchor due to negative earnings and no dividend.
To see Spark’s full report on DRIO stock, click here.
More about DarioHealth
Average Trading Volume: 23,807
Technical Sentiment Signal: Strong Sell
Current Market Cap: $67.72M
For an in-depth examination of DRIO stock, go to TipRanks’ Overview page.